Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
83.1M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
3.87M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$6.57M
-
Value change
-
+$2.16M
-
Put/Call ratio
-
1.27
-
Number of buys
-
25
-
Number of sells
-
-9
-
Price
-
$1.70
Significant Holders of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) as of Q3 2023
45 filings reported holding CKPT - Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value as of Q3 2023.
Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.87M shares
of 83.1M outstanding shares and own 4.65% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.06M shares), VANGUARD GROUP INC (483K shares), SABBY MANAGEMENT, LLC (205K shares), GEODE CAPITAL MANAGEMENT, LLC (173K shares), PVG ASSET MANAGEMENT CORP (111K shares), OSAIC HOLDINGS, INC. (107K shares), BlackRock Inc. (104K shares), Legacy Wealth Asset Management, LLC (85K shares), PARK AVENUE SECURITIES LLC (59.9K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (54.9K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.